Veradermics Inc. MANE
$92.71
▲ +1.77% 24H
About
Veradermics Inc. is a dermatologist-founded, late clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for prevalent aesthetic and dermatological conditions. Its primary focus centers on pattern hair loss, affecting approximately 50 million men and 30 million women in the United Stat…
SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees24
TickerMANE
Statistics
Market Cap$3.46B
Revenue (TTM)—
Net Income-$70.0M
Net Margin—
EPS$-111.91
P/E-48.09
P/S—
P/B9.02
EV/EBITDA-54.57
ROE68.9%
Dividend Yield—
Price$92.71
Data: Twelve Data · Revenue = mcap / P/S